Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.
EMBO Mol Med
; 7(4): 394-410, 2015 Apr.
Article
in En
| MEDLINE
| ID: mdl-25700171
Full text:
1
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Drug Delivery Systems
/
Potassium Channel Blockers
/
Myocytes, Cardiac
/
Pluripotent Stem Cells
/
Models, Biological
Type of study:
Prognostic_studies
Language:
En
Journal:
EMBO Mol Med
Year:
2015
Type:
Article